Schellenberg Wittmer, Simmons & Simmons and Jones Day acted as legal counsel for ATP adhesive systems AG on the deal. Baker McKenzie acted for UBS Switzerland...
You must be a Standard 1 Year member to access this content.
Schellenberg Wittmer advised SIX Swiss Exchange-listed ams-OSRAM AG on the sale of its Passive Optical Components Assets. Focuslight Technologies Inc., a global provider of high-power diode...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised UBS Switzerland AG as mandated lead arranger, lender, agent and security agent, while Schellenberg Wittmer acted as Swiss legal counsel to Meeberg Leasing...
You must be a Standard 1 Year member to access this content.
Schellenberg Wittmer advised Boerhringer Ingelheim on the deal. Boehringer Ingelheim has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines...
You must be a Standard 1 Year member to access this content.
Schellenberg Wittmer advised HOCHDORF Holding AG on the deal. Schellenberg Wittmer advised SIX Swiss Exchange-listed HOCHDORF Holding AG, a Swiss market leader in milk processing, specialising...
You must be a Standard 1 Year member to access this content.
Schellenberg Wittmer advised Trianon on the authorization process. Trianon obtained its FINMA license as asset manager of collective assets with the Swiss Financial Supervisory Authority (FINMA)....
You must be a Standard 1 Year member to access this content.
Schellenberg Wittmer advised Emerald Technology Ventures. Cleantech venture capital pioneer Emerald Technology Ventures obtained its FINMA license as asset manager of collective assets with the Swiss Financial...
You must be a Standard 1 Year member to access this content.
Allen & Overy acted as Luxembourg counsel, while Schellenberg Wittmer Ltd. provided the Swiss law advice. Teylor AG, a Swiss fintech lending platform, has successfully executed...
You must be a Standard 1 Year member to access this content.
Schellenberg Wittmer advised Bioventure on series C financing round. Bioventure Club Deal Nine GmbH & Co KG on a Series C Financing Round of the Swiss...
You must be a Standard 1 Year member to access this content.
Schellenberg Wittmer advised Gilde Healthcare on the deal. Gilde Healthcare’s Private Equity Fund (Gilde Healthcare), a specialized healthcare investor, completed the acquisition of a majority of the...
You must be a Standard 1 Year member to access this content.
Schellenberg Wittmer advised Swiss asset manager Reichmuth Infrastructure on the financing. Reichmuth Infrastructure has further expanded its renewables footprint in Germany with a joint venture to...
You must be a Standard 1 Year member to access this content.
Schellenberg Wittmer advised Santhera Pharmaceuticals Holding AG on the operation. Schellenberg Wittmer advised Santhera Pharmaceuticals Holding AG on the sale of its Raxone®/idebenone business for all...
You must be a Standard 1 Year member to access this content.
